Search

everythinglearnresearchcommunity

for

Search:↓

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Skin issues can indicate immune system problems.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Belatacept may be a promising treatment for alopecia areata.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

Epigenetic changes contribute to autoimmune skin diseases.

Anti-CD19 therapy may help treat SLE and NMOSD.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Polysaccharides boost immunity and could help prevent and treat diseases.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Keratin 14 may be an autoantigen in autoimmune skin diseases.

Fetal skin has unique immune cells different from adult skin.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

A new compound from Royoporus badius activates immune cells and induces inflammatory responses.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

ILC1-like cells may contribute to hair loss in alopecia areata.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.